Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

• Main Authors: Kei Irie (Author), Atsushi Nakagawa (Author), Hirotoshi Fujita (Author), Ryo Tamura (Author), Masaaki Eto (Author), Hiroaki Ikesue (Author), Nobuyuki Muroi (Author), Keisuke Tomii (Author), Tohru Hashida (Author)
• Format: Book
• Published: Wiley, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Since December 2019, a novel coronavirus (severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)) infection has been rapidly spreading worldwide and causing the respiratory illness, coronavirus disease 2019 (COVID‐19). The antiretroviral drug favipiravir (FPV) has been experimentally used for...